{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-042926","form_type":"8-K","ticker":"PURE","cik":"0001006028","company_name":"PURE BIOSCIENCE, INC.","filed_at":"2024-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.330002+00:00","generated_at":"2026-05-30T08:50:19.067429+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"PURE Bioscience reports FY 2024 net loss of $3.4M; product sales up 4.5% to $1.955M","bullets":["Net product sales $1.955M in FY 2024 vs $1.871M in FY 2023, up $84K (4.5%).","Net loss improved to ($3.4M) from ($3.9M); net loss per share ($0.03) vs ($0.04).","Net cash used in operations reduced to ($2.5M) from ($3.3M).","Shifted strategy to distribution model; partnered with multiple distributors in fiscal 2024.","R&D focused on Clean-in-Place solutions for food processing equipment sanitation."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-042926","json":"https://secwatch.observer/filing/0001493152-24-042926.json","markdown":"https://secwatch.observer/filing/0001493152-24-042926.md","text":"https://secwatch.observer/filing/0001493152-24-042926.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006028/000149315224042926/0001493152-24-042926-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006028/000149315224042926/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T08:50:19.067429+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}